Paper772425
Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
Woods JW and 5 others. N Engl J Med, 1976. Cited by 110 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone. Papers, record 772425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/772425
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorthalidone | Major topic |
| Hypertension | Major topic |
| Propranolol | Major topic |
| Renin | Major topic |
| Adult | |
| Age Factors | |
| Black People | |
| Blood Pressure | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Posture | |
| Prospective Studies | |
| Sex Factors | |
| Sodium | |
| White People |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,697,680 | Metabolomics, Lipid Pathways, and Blood Pressure Change. | Arterioscler Thromb Vasc Biol | 2020 | https://conductscience.org/library/papers/32697680 | PubMed |
| 28,057,892 | Hypothalamic and inflammatory basis of hypertension. | Clin Sci (Lond) | 2017 | https://conductscience.org/library/papers/28057892 | PubMed |
| 27,587,277 | Influence of Age and Race on 24-Hour Ambulatory Blood Pressure Responses to Valsartan, Hydrochlorothiazide, and Their Combination: Implications for Clinical Practice. | J Clin Hypertens (Greenwich) | 2017 | https://conductscience.org/library/papers/27587277 | PubMed |
| 25,693,856 | Environmental origins of hypertension: phylogeny, ontogeny and epigenetics. | Hypertens Res | 2015 | https://conductscience.org/library/papers/25693856 | PubMed |
| 21,814,209 | The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain. | Hypertens Res | 2011 | https://conductscience.org/library/papers/21814209 | PubMed |
| 20,725,057 | Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. | Am J Hypertens | 2010 | https://conductscience.org/library/papers/20725057 | PubMed |
| 18,749,429 | Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms. | West J Med | 1983 | https://conductscience.org/library/papers/18749429 | PubMed |
| 7,032,946 | The response to the angiotensin antagonist saralasin in predicting therapeutic outcome in hypertension treated with frusemide. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7032946 | PubMed |
| 7,030,750 | Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7030750 | PubMed |
| 6,994,760 | A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6994760 | PubMed |
| 6,992,462 | Antihypertensive pharmacology. | West J Med | 1980 | https://conductscience.org/library/papers/6992462 | PubMed |
| 3,891,306 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. | Drugs | 1985 | https://conductscience.org/library/papers/3891306 | PubMed |
| 3,889,356 | Propranolol versus labetalol: interesting differences in efficacy. | J Natl Med Assoc | 1985 | https://conductscience.org/library/papers/3889356 | PubMed |
| 1,980,202 | The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/1980202 | PubMed |
| 902,672 | Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients. | Eur J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/902672 | PubMed |
| 359,018 | Acebutolol in hypertension--double-blind trial against placebo. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/359018 | PubMed |
| 23,284 | Antihypertensive drugs: clinical pharmacology and therapeutic use. | Drugs | 1977 | https://conductscience.org/library/papers/23284 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5,972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/772425
GET https://conductscience.org/api/papers/v1/772425/authors